High ‐level βIII‐tubulin overexpression occurs in most head and neck cancers but is unrelated to clinical outcome

ConclusionDespite lacking prognostic utility in HNSCC, the remarkable high prevalence of TUBB3 expression in HNSCC emphasizes its putative relevance as a target for future drugs targeting TUBB3.

Source: Journal of Oral Pathology and Medicine - July 9, 2017 Category: Pathology Authors: Julie C. Nienstedt, Alexander Gr öbe, Till Clauditz, Ronald Simon, Adrian Muenscher, Rainald Knecht, Guido Sauter, Christoph Moebius, Marco Blessmann, Max Heiland, Christina Pflug Tags: ORIGINAL ARTICLE Source Type: research